Advertisement
Advertisement
CTI BioPharma Corp. (CTIC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
As of 11:28AM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Currency in USD
Valuation Measures4
Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly dataMonthly
Subscribe to Yahoo Finance Plus Essential to download historical data| As of Date: 1/30/2023Current | |
|---|---|
| Market Cap (intraday) | N/A |
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.91 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 7.80 |
| 52 Week Low 3 | 1.82 |
| 50-Day Moving Average 3 | 5.71 |
| 200-Day Moving Average 3 | 5.65 |
Share Statistics
| Avg Vol (3 month) 3 | 3.08M |
| Avg Vol (10 day) 3 | 2.71M |
| Shares Outstanding 5 | 96.69M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 97.29M |
| % Held by Insiders 1 | 0.22% |
| % Held by Institutions 1 | 84.25% |
| Shares Short (Oct 13, 2022) 4 | 17.62M |
| Short Ratio (Oct 13, 2022) 4 | 3.96 |
| Short % of Float (Oct 13, 2022) 4 | 16.74% |
| Short % of Shares Outstanding (Oct 13, 2022) 4 | 15.40% |
| Shares Short (prior month Sep 14, 2022) 4 | 17.06M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jan 02, 2017 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jan 02, 2017 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Jun 29, 2022 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -695.70% |
Management Effectiveness
| Return on Assets (ttm) | -59.98% |
| Return on Equity (ttm) | -428.11% |
Income Statement
| Revenue (ttm) | 14.62M |
| Revenue Per Share (ttm) | 0.15 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -100.59M |
| Net Income Avi to Common (ttm) | -120.8M |
| Diluted EPS (ttm) | -0.74 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 95.87M |
| Total Cash Per Share (mrq) | 0.84 |
| Total Debt (mrq) | 109.02M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.60 |
| Book Value Per Share (mrq) | 0.53 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -100.74M |
| Levered Free Cash Flow (ttm) | -51.05M |
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
